Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AAK1 | Q2M2I8 | 3/20 | 0.44 |
| ▸ | FPR2 | P25090 | 5/20 | 0.44 |
| ▸ | PLAU | P00749 | 2/20 | 0.40 |
| ▸ | HPN | P05981 | 2/20 | 0.40 |
| ▸ | NPR3 | P17342 | 1/20 | 0.40 |
| ▸ | JAK2 | O60674 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | MMP13 | P45452 | 4/20 | 0.39 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.36 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.36 |
| ▸ | PTPN6 | P29350 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22143981 | 0.99 | AAK1 (0.44) | AAK1FPR2PLAUHPNNPR3 | |
| SCHEMBL24593528 | 0.99 | AAK1 (0.44) | AAK1FPR2PLAUHPNNPR3 | |
| SCHEMBL28603119 | 0.99 | AAK1 (0.44) | AAK1FPR2PLAUHPNNPR3 | |
| SCHEMBL28603117 | 0.99 | AAK1 (0.44) | AAK1FPR2PLAUHPNNPR3 | |
| SCHEMBL22125809 | 0.90 | AAK1 (0.41) | AAK1FPR2JAK2MEN1KMT2A | |
| SCHEMBL22143677 | 0.88 | AAK1 (0.42) | AAK1FPR2PLAUHPNNPR3 | |
| SCHEMBL22125806 | 0.86 | MEN1 (0.42) | AAK1JAK2MEN1KMT2APTPN2 | |
| SCHEMBL28614586 | 0.86 | MEN1 (0.42) | AAK1JAK2MEN1KMT2APTPN2 | |
| SCHEMBL28617671 | 0.84 | S1PR1 (0.46) | AAK1FPR2PLAUHPNNPR3 | |
| SCHEMBL28604846 | 0.84 | S1PR1 (0.46) | AAK1FPR2PLAUHPNNPR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11377425-B1 | Small molecule modulators of IL-17 | LEO PHARMA A/S (DK) | 2022-07-05 | — | — | US | disclosed |
| CN-113164448-A | Amino acid anilines as small molecule modulators of IL-17 | 利奥制药有限公司 | 2021-07-23 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11377425-B1 | Small molecule modulators of IL-17 | IL17A, IL15, IL2 | AAK1 2606/4885FPR2 1351/4885PLAU 2608/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.